Loading...

Abbvie Inc (NYSE:ABBV)

152.34 USD +2.89 USD ( +1.93% )
Watchlist Manager
Abbvie Inc Logo
Abbvie Inc
NYSE:ABBV
Watchlist

P/E
Price to Earnings

The Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.

P/E
=
Market Cap
/
Net Income
Current P/E
ABBV
21.6
Median P/E
ABBV
22.7
Industry P/E
Biotechnology
4.7

P/E History

Statistics
Price to Earnings

1 Year 3 Years 5 Years
Average 25.4 24.5 22.1
Median 24.8 22.7 20.6
Min 20.4 11.6 11.6
Max 36.8 39.3 39.3

History Chart
Price to Earnings

P/E Forward Multiples

Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/E
10.7
2-Years Forward
P/E
12.5
3-Years Forward
P/E
12.6

P/E Across Competitors

ABBV Competitors
Abbvie Inc Competitors

Country Company Market Cap P/E
US
Abbvie Inc
NYSE:ABBV
269B USD 21.6
US
Amgen Inc
NASDAQ:AMGN
131B USD 22.9
AU
CSL Ltd
ASX:CSL
128B AUD 38.3
US
Gilead Sciences Inc
NASDAQ:GILD
79.2B USD 17.5
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
74.8B USD 30.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
67.1B USD 8.5

Relative Valuation Report

View full relative valuation report for Abbvie Inc, which takes into account all ABBV`s valuation multiples.

See Also

Similar Stocks